Tim Sullivan

Tim Sullivan is a seasoned business executive with extensive experience in the biopharmaceutical industry. Currently serving as the Chief Business Officer at Infinimmune since September 2024, Tim previously held the same title at Spring Discovery from June 2021 to September 2024. Prior roles include Vice President of Business Development at Arcus Biosciences and Senior Director of External R&D Innovation at Pfizer. Tim's early career features leadership positions at Takeda Pharmaceuticals, ChemoCentryx, Amgen, and Tularik. Tim holds a Ph.D. in Immunology from the University of California, Berkeley, and a B.A. in Biology and Psychology from the University of Notre Dame.